Get the Stockscreener App
8.26
1.23%
0.10
Lifemd Inc stock is traded at $8.26, with a volume of 1.35M.
It is up +1.23% in the last 24 hours and up +58.85% over the past month.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
See More
Previous Close:
$8.16
Open:
$8.17
24h Volume:
1.35M
Relative Volume:
0.83
Market Cap:
$323.23M
Revenue:
$193.06M
Net Income/Loss:
$-22.51M
P/E Ratio:
-12.91
EPS:
-0.64
Net Cash Flow:
$10.63M
1W Performance:
+13.93%
1M Performance:
+58.85%
6M Performance:
+41.20%
1Y Performance:
-11.18%
1-Day Range:
$7.96
$8.452
1-Week Range:
$7.11
$8.54
52-Week Range:
$3.99
$9.87
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Compare LFMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMD
Lifemd Inc
|
8.26 | 323.23M | 193.06M | -22.51M | 10.63M | -0.64 |
|
VEEV
Veeva Systems Inc
|
237.05 | 38.54B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.19 | 11.13B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
61.37 | 9.87B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
90.40 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.01 | 7.04B | 906.14M | -52.62M | 89.62M | -0.3621 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Initiated | Lake Street | Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-23-24 | Resumed | B. Riley Securities | Buy |
| Jun-05-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-30-23 | Initiated | Craig Hallum | Buy |
| Jul-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-03-23 | Initiated | H.C. Wainwright | Buy |
| Mar-10-22 | Initiated | Colliers Securities | Buy |
| Oct-04-21 | Resumed | B. Riley Securities | Buy |
View All
Lifemd Inc Stock (LFMD) Latest News
LifeMD Might Run Higher (NASDAQ:LFMD) - Seeking Alpha
LifeMD, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - simplywall.st
LifeMD raises 2025 revenue guidance to $275M driven by telehealth growth - MSN
Trading (LFMD) With Integrated Risk Controls - news.stocktradersdaily.com
(LFMDP) Investment Report - news.stocktradersdaily.com
Cantor Fitzgerald maintains Overweight on LifeMD shares, target $15.00 By Investing.com - Investing.com Nigeria
LifeMD’s Earnings Call: Positive Growth and Strategic Expansion - TipRanks
Cantor Fitzgerald maintains Overweight on LifeMD shares, target $15.00 - Investing.com Australia
BTIG maintains Buy rating, $12 target on LifeMD shares By Investing.com - Investing.com Nigeria
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 50% Yet They're Still Not Telling The Full Story - simplywall.st
LifeMD, Inc. (NASDAQ:LFMD) Q1 2025 Earnings Call Transcript - Insider Monkey
BTIG maintains Buy rating, $12 target on LifeMD shares - Investing.com
LifeMD (LFMD) Exceeds Q1 Expectations and Raises 2025 Outlook - GuruFocus
LifeMD Inc (LFMD) Q1 2025 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance
LifeMD earnings beat by $0.07, revenue topped estimates - Investing.com Canada
LifeMD (LFMD) Reports Strong Q1 2025 Performance and Raises Guid - GuruFocus
LifeMD Inc Reports Q1 2025 Earnings: EPS of $0.01 Beats Estimates, Revenue Surges to $65.7 Million - GuruFocus
LifeMD Inc reports results for the quarter ended March 31Earnings Summary - TradingView
LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Earnings call transcript: LifeMD Q1 2025 earnings beat expectations, stock rises - Investing.com
LifeMD (LFMD) Boosts FY25 Revenue and EBITDA Forecasts | LFMD Stock News - GuruFocus
LifeMD (LFMD) Surpasses Revenue Expectations with Strong Q1 Performance | LFMD Stock News - GuruFocus
LifeMD, Inc. SEC 10-Q Report - TradingView
LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance - GlobeNewswire
LifeMD Crushes Q1 Expectations: 70% Telehealth Surge and Historic Profit Milestone - Stock Titan
LifeMD (LFMD) Sees High Call Activity Ahead of Earnings | LFMD Stock News - GuruFocus
LifeMD, Inc. Reports Strong Q1 2025 Results - TipRanks
LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expec - GuruFocus
LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Have LifeMD Insiders Been Selling Stock? - simplywall.st
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk's Plan To Sell Wegovy Via Telehealth Operators - MSN
LifeMD Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
LifeMD (LFMD) to Announce Q1 2025 Earnings and Host Conference C - GuruFocus
LifeMD (LFMD) Enhances Access to Wegovy with NovoCare Partnershi - GuruFocus
Novo Nordisk partners with Hims & Hers, Ro, LifeMD to offer discounted Wegovy - eMarketer
LifeMD expands access to weight management drug Wegovy - Investing.com
Why Hims & Hers Health and LifeMD Are Skyrocketing Today - Mitrade
Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy - MSN
LifeMD Stock Pops As Company Expands Weight-Loss Offerings With Wegovy - Benzinga
Wegovy to be sold on Hims, Ro and LifeMD for reduced price - Yahoo
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk’s Plan To Sell Wegovy Via Telehealth Operators By Stocktwits - Investing.com India
LifeMD and Hims & Hers Health shares surge on Novo Nordisk partnerships - Investing.com
LifeMD (LFMD) Expands Access to Wegovy with NovoCare Partnership - GuruFocus
LifeMD Expands Access to Weight-Loss Drug Wegovy; Shares Surge - marketscreener.com
LifeMD Shares Surge on Expanded Access to Wegovy - MarketWatch
LifeMD Announces Plans to Expand Affordable Access to Wegovy® fo - GuruFocus
LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients - The Manila Times
LifeMD Makes Wegovy More Affordable: New $499 Monthly Program Includes Home Delivery - Stock Titan
LifeMD buys key assets from Optimal Human Health MD - MSN
LifeMD, Inc. (NASDAQ:LFMD) Receives $11.00 Average Price Target from Brokerages - Defense World
LifeMD to Report First Quarter 2025 Financial Results on May 6 - GlobeNewswire
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lifemd Inc Stock (LFMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schreiber Justin | Chairman and CEO |
May 02 '25 |
Sale |
7.50 |
3,005 |
22,539 |
2,550,721 |
| Schreiber Justin | Chairman and CEO |
Apr 29 '25 |
Sale |
7.78 |
50,000 |
389,040 |
2,575,721 |
0.13%
0.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):